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Sputum cultureAbstract Background: Moraxella catarrhalis is an exclusively human pathogen that may be over-
looked in culture because of its phenotypic similarity to commensal Neisseria. Indeed, beta lacta-
mase producing isolates of M. catarrhalis appear to be wide spread, and this may play an
important role in the therapy of infections, particularly in the treatment of mixed infections
Objective: The purpose of this study was to evaluate the significance ofM. catarrhalis as a patho-
gen in causing lower respiratory tract infection.
Methods: This study was carried out on 200 patients who were diagnosed as having lower res-
piratory tract infection and admitted during the period of the research to chest unit of Tanta
University hospitals, another 50 adult volunteer were considered as control group during the period
from January 2014 to August 2014. All patients were subjected to the following assessment, full
clinical history; their records were reviewed for name, age, sex, and special habits. Patients sus-
pected to be suffering from lower respiratory tract infection were considered. Only sputum samples
of high bacteriological quality were analyzed. All specimens were cultured.
Result: M. catarrhalis is responsible for 11.5% of all cases of lower respiratory tract infection
included in this study. Infection occurs more common in patients having underlying lung disease
especially chronic pulmonary diseases.
Conclusion: This study shows that when microbiological and clinical criteria are met,
M. catarrhalis when isolated should be considered as a pathogen causing lower respiratory tract
infections. M. catarrhalis, lower respiratory tract infections.
 2016 The Egyptian Society of Chest Diseases and Tuberculosis. Production and hosting by Elsevier B.V.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-
nd/4.0/).Introduction
Moraxella catarrhalis is a Gram negative, aerobic, diplococcus
frequently found as a commensal of the upper respiratory
tract. Colonies on blood agar are non-hemolytic, round, opa-
que, convex, and grayish white. The gram negative diplococcusgypt. J.
2 M.O. Ramadan et al.is difficult to distinguish from Neisseria spp. in a typical Gram
staining. Various biochemical test methods exist to distinguish
the species.M. catarrhalis is DNAse, catalase and oxidase pos-
itive, furthermore the pathogen hydrolyzes tributyrin, reduces
nitrate and is unable to produce acid from glucose, lactose,
maltose fructose and sucrose. None of these tests are 100%
sensitive or specific. The informative value of more sensitive
DNA methods such as polymerase chain reaction (PCR) has
been demonstrated [1].
Two major phylogenetic subpopulations (type 1 and type 2
strains) of the species have been identified. [2]. The virulence
factors for M. catarrhalis include; Lipo-oligosaccharide
(LOS) of the cell wall, complement resistance and the polysac-
charide capsule [3].
The genus Moraxella
The genus Moraxella belongs to the family Moraxellaceae,
which includes the closely related genera Acinetobacter and
Psychrobacter. The Moraxella genus itself currently contains
15 different species. Although all these 16 species have been
classified within the genus Moraxella, the classification of the
Moraxellaceae family is still not definitive but continuously
evolving. In adults the pharyngeal carriage rate is noticeably
lower and varies between 1% and 5%. It increases again in
adults older than 60 years of age [4].
Two distinct genetic lineages related to 3 different 16S
rRNA types have been identified for M. catarrhalis, which dif-
fer phenotypically in their ability to resist the killing effect of
human serum (sero-resistant versus sero-sensitive), and in their
ability to adhere to human epithelial cells [5]. It is known that
M. catarrhalis exists in biofilms and that it is able to prolong its
survival through biofilm formation on mucosal surfaces in the
nasopharynx [6]. Biofilm formation has been demonstrated for
numerous pathogens and is clearly an important microbial sur-
vival strategy [7]. Furthermore, several nosocomial outbreaks
of respiratory disease due to M. catarrhalis infections in adults
and in children have been reported [8]. In children,M. catarrhalis
causes mainly upper respiratory tract infections (otitis media),
whereas in adults the pathogen causes lower respiratory tract
infections in previously compromised airways (acute exacerba-
tion of Chronic Obstructive Pulmonary Disease [COPD]). Inva-
sive infections such as bacteraemia, meningitis, septic arthritis,
ventriculitis and endocarditis, are very rare [9].
Of added importance, and perhaps contributing to the
apparent increase in M. catarrhalis as a respiratory tract
pathogen, has been the production of beta-lactamase enzymes.
There has been rapid acquisition and spread of beta lactam
antibiotic resistance of M. catarrhalis in the last 20–30 years
to the extent that approximately 95–99% of clinical isolates
now appear to resist one or more beta lactam antibiotics [10].
Aim of the work
The aim of this study was to evaluate the significance of M.
catarrhalis as a pathogen in causing lower respiratory tract
infection, characterize the cell surface hydrophobicity and
beta-lactamase production of M. catarrhalis as important vir-
ulent factors (see Figs. 1–4).Please cite this article in press as: M.O. Ramadan et al., Significance of Moraxella ca
Chest Dis. Tuberc. (2016), http://dx.doi.org/10.1016/j.ejcdt.2016.05.011Materials and methods
The present study was carried out in Microbiology and
Immunology Department, Faculty of Medicine, Tanta Univer-
sity, on 200 patients who were clinically diagnosed as having
lower respiratory tract infection and admitted in the period
from January 2014 to August 2014 to chest unit of Tanta
University hospitals. Full clinical history was taken from the
selected patients and their records were reviewed for name,
age, sex, special habits, clinical diagnosis on admission, clinical
signs of infection and immune suppression status e.g. steroid
therapy, malignancy or diabetes mellitus. Patients with
immune suppression status were excluded. The most common
primary underlying disease was Chronic Obstructive Pul-
monary Disease (COPD), in addition to bronchiectasis
and pulmonary fibrosis. Another 50 (29 male and 21 female)
apparently healthy volunteers with no symptoms and signs
suggesting respiratory tract infection were included in this
study as a control group. The age was ranging from 20 to
73 years (mean age 57). History of smoking was present in
17 individual.
A. Sample collection and transport: Sputum samples: Early
morning sputum samples were obtained from 200 patients.
Every patient was instructed to brush his or her teeth and to
gargle with water immediately before obtaining the sputum
sample to reduce the number of contaminations with oropha-
ryngeal bacteria [12].
Throat swabs
Throat swabs were obtained from healthy control subjects. A
bright light from over the shoulder of the specimen collector
was focused into the oral cavity so that the swab can be guided
to the posterior pharynx [12].
Processing of specimens:
(1) Microscopy: smears were prepared from the most puru-
lent part of the sputum samples and stained with Gram
stain [13]. Only sputum samples of high bacteriological
quality were analyzed (<10 epithelial cells, >25 leuco-
cytes/low power field) [14].
(2) Culture: all specimens were inoculated on blood, choco-
late, McConkey, and Sabouraud agar. The inoculated
blood and chocolate plates were incubated at 37 C for
24 h in candle jar containing 3–5% Co2.
The following criteria were considered for determining
pathogenic significance of an isolate [14]:
(1) Clinical evidence of infection consistent with the disease
spectrum associated with M. catarrhalis (cough with
sputum production).
(2) M. catarrhalis as a predominant potential pathogen iso-
lated from an appropriate and adequate specimen.
(3) Clinical response on treatment with antibiotic to which
the isolate was susceptible.
Taking the above mentioned criteria into consideration, as
follows:-tarrhalis as a causative organism of lower respiratory tract infections, Egypt. J.
Figure 1 Adherence to host epithelial cells [11].
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Figure 4 Prevalence of Moraxella catarrhalis isolation in the
control group.
Significance of Moraxella catarrhalis as a causative organism of lower respiratory tract infections 3 Significant isolate: if criteria 1, 2 and 3 were present.
 Probably significant isolate: if criteria 1 and 2 were present
and 3 could not be assessed.
 Indeterminate isolate: if only criterion 1 was present.Please cite this article in press as: M.O. Ramadan et al., Significance of Moraxella ca
Chest Dis. Tuberc. (2016), http://dx.doi.org/10.1016/j.ejcdt.2016.05.011Results
This work was carried out in the microbiology and immunol-
ogy department, faculty of medicine, Tanta University in the
period from January 2014 to August 2014. This study com-
prised 200 patients who were clinically diagnosed as having
lower respiratory tract infection and admitted during the per-
iod of the research to the chest unit of Tanta University hospi-
tals. Another 50 apparently healthy volunteers with no
symptoms and signs suggesting respiratory tract infection were
also included in this study as a control group. The results of
this study were collected analyzed and tabulated as follows
(see Tables 1–8).tarrhalis as a causative organism of lower respiratory tract infections, Egypt. J.
Table 2 Sex distribution of the patient group.
Sex No. of patients (n= 200) %
Male 123 61.5
Female 77 38.5
Table 3 Percentage of different clinical findings in the patient
group.
Clinical findings No. of patients (n= 200) %
Purulent sputum 138 69
Fever 113 56.5
Wheezes 87 43.5
Haemoptysis 17 8.5
Positive findings in chest X-ray 144 72
Table 4 Prevalence of different organisms’ isolation in the
patient group.
Organism No. of isolates (n= 200) %
Streptococcus pneumoniae 34 17
Candia species 17 8.5
Acinetobacter species 17 8.5
Kingella kingae 2 1
Moraxella catarrhalis 23 11.5
Klebsiella spp. 22 11
Staphylococcus aureus 22 11
Pseudomonas aeruginosa 21 10.5
Haemophilus influenza 1 0.5
Streptococcus pyogenes 10 5
Neisseria meningitidis 1 0.5
E. coli 4 2
Stenotrophomonas maltophilia 1 0.5
Commensals 20 10
No growth 5 2.5
Table 5 Percentage of age related Moraxella catarrhalis
isolates to the total number of Moraxella catarrhalis isolated
in the patient group.
Age
group
No. of isolates
(n= 23)
% to the total
isolates
20–50 7 30.4 Chi-Sq = 7.043
>50 16 69.6 P-Value = 0.008
4 M.O. Ramadan et al.Discussion
M. catarrhalis is an exclusively human commensal and muco-
sal pathogen. Its role as a disease-causing organism has long
been questioned [15]. In general, the organism is mostly asso-
ciated with upper respiratory tract infections especially in chil-
dren and lower respiratory tract infections in adults especially
exacerbations of Chronic Obstructive Pulmonary Disease
(COPD). [11]. This study was performed on the sputa of 200
patients who were clinically diagnosed as having lower respira-
tory tract infection, in addition to another 50 throat swabs
from 50 adult healthy volunteers as a control group. The
prevalence of M. catarrhalis isolation in patient group was
11.5%. This result is not far from that of Mackenzie et al.
[16]who reported that 17.1% of adult patients with respiratory
tract infections were due to M. catarrhalis. In early reports the
recognition of M. catarrhalis as a human lower respiratory
tract pathogen has been delayed for several reasons. One of
these reasons is that the organism was considered as an upper
respiratory tract commensal [17].
In this study 69.6% of the patient isolates were from
patients aged over 50 years. Anita et al. [18] reported a similar
percentage which was 68% from the same age group.
In this study they only focused on pure cultures which
explain the lower percentage of M. catarrhalis isolation rate
in this age group. The Prevalence of M. catarrhalis isolation
in our control group was 10%. Of that 2% was isolated from
control subjects aged from 20 to 50 years and 8% was isolated
from control subjects aged over 50 years. A percentage of
11.7% for control subjects aged over 50 years was reported
by Sehgal and Al Shaimy [19], which is close to our result.
The most common isolated organisms other thanM. catarrhalis
in our patient group were Streptococcus pneumoniae, Klebsiella
pneumoniae and Staphylococcus aureus.
In the patient group 60.9% of our isolate were from males
and 39.1% were from females. Tamang et al. [13] reported sim-
ilar male to female ratio which was 64% from male and 36%
from female patient. A higher male ratio is probably due to the
habit of smoking, which is more common among males.
65.2% ofM. catarrhalis isolates in the patient group were in
winter months. Similar data were reported by George et al. [20]
who found that infection with M. catarrhalis was more com-
mon in winter months. The organism was isolated from con-
trol subjects in winter months in a significant higher rate
than spring and summer months (P-value < 0.001). A rate
which agrees with the result was reported by Hendley et al.
[21].
History of smoking was present in 65.2% of the patient
group. Similar finding was reported by Nicolas et al. [22]
and 1991. Kurtti et al. [23]described that the antibody titers
against M. catarrhalis were significantly higher in smokers
than non smokers.Table 1 Age distribution of the patient group.
Age group No. of patients (n = 200) %
20–50 year 116 58
>50 year 84 42
Please cite this article in press as: M.O. Ramadan et al., Significance of Moraxella ca
Chest Dis. Tuberc. (2016), http://dx.doi.org/10.1016/j.ejcdt.2016.05.011COPD was identified as a risk factor for development ofM.
catarrhalis lower respiratory tract infection. In our patient
group COPD cases represent 60.9% of all cases of M. catar-
rhalis infection. A much higher incidence 76% was observed
by Ahmed et al. [24]. A much lower incidence 37% was
reported by Anita et al. [18].
Antibiotic susceptibility testing revealed that 91.3% of the
strains isolated from patient group were resistant to Penicillin.
Surveys of resistance in the UK in 1991 showed that 91% of
M. catarrhalis strains, respectively, were resistant to Penicillin.tarrhalis as a causative organism of lower respiratory tract infections, Egypt. J.
Table 6 Distribution of Moraxella catarrhalis isolation in
patient group over months of the year (2014).
Month No. of isolates (n= 23) %
January 8 34.8
February 4 17.4
March 3 13
April 4 17.4
May 3 13
June 1 4.3
July 0 0
August 0 0
Table 7 Antibiotic susceptibility of Moraxella catarrhalis
isolated from the patient group.
Antibiotic Moraxella catarrhalis (n= 23)
Sensitive Resistant
No. of
isolates
% No. of
isolates
%
Penicillin (10 lg) 2 8.7 21 91.3
Amoxicillin–clavulanic
acid (20 lg)
23 100 0 0
Cefaclor (5 lg) 22 95.7 1 4.3
Cefuroxime (30 lg) 23 100 0 0
Ceftriaxone (30 lg) 23 100 0 0
Ciprofloxacin (5 lg) 23 100 0 0
Erythromycin (15 lg) 23 100 0 0
Tetracycline (30 lg) 22 95.7 1 4.3
Gentamycin (10 lg) 23 100 0 0
Co-trimoxazole (25 lg) 23 100 0 0
Table 8 Beta-lactamase production and hydrophobicity of
Moraxella catarrhalis isolates in patient and control groups.
Beta-lactamase
production
Hydrophobicity
Positive Negative Hydrophobic Hydrophillic
No. % No. % No. % No. %
Patient
group
Isolates
(n= 23)
22 95.7 1 4.3 18 78.3 5 21.7
Control
group
Isolates
(n= 5)
4 80 1 20 1 20 4 80
Significance of Moraxella catarrhalis as a causative organism of lower respiratory tract infections 5An important factor in the pathogenesis of numerous dis-
eases is hydrophobicity. It is related to the adhesive ability
of the organism, adhesive ability increases as the cell surface
hydrophobicity increases and decreases as the cell surface
hydrophobicity decreases [25]. Janicka et al. [25]found that
hydrophobic strains ofM. catarrhalis were isolated more often
from sputum rather than from nose and throat swabs, and that
hydrophillic strains were found in statistically significant inci-
dence in samples from upper (48.7%) than lower (10.5%) res-
piratory tract.Please cite this article in press as: M.O. Ramadan et al., Significance of Moraxella ca
Chest Dis. Tuberc. (2016), http://dx.doi.org/10.1016/j.ejcdt.2016.05.011Conclusions
From the present study, it could be concluded that
M. catarrhalis is responsible for 11.5% of all cases of lower res-
piratory tract infection in the study. Infection and colonization
occur more commonly in elderly patients. Infection occurs
more common in patients having underlying chronic pulmonary
diseases and in smokers. Most of the pathogenic strains were
beta-lactamase producers and hydrophobic and most of the
pathogenic strains were susceptible to all tested antibiotics.
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